|
Delayed
Nasdaq
16:00:00 2026-04-24 EDT
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-28 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.21% | -.--% | -.--% | -.--% | +1.76% | +60.47% | +31.97% | +25.78% | +112.78% | 4.55B | |
| -2.37% | -4.19% | -17.14% | +7.96% | +52.97% | +39.49% | +63.21% | +6.51% | - | 63.77B | |
| -2.68% | +0.62% | -3.73% | +8.70% | +9.51% | +10.59% | +69.40% | +187.65% | +5,851.48% | 56.37B | |
| +0.54% | +2.08% | +14.57% | +15.67% | +20.49% | +20.18% | +102.50% | -16.45% | +256.04% | 54.62B | |
| -2.09% | -3.78% | +1.96% | +12.81% | +16.79% | +23.09% | +38.22% | +2.11% | +263.82% | 44.06B | |
| -1.86% | -2.01% | +1.49% | +15.82% | +19.61% | +16.53% | +99.62% | +1.41% | +999.21% | 42.11B | |
| -1.34% | +3.60% | -7.80% | +4.42% | +139.19% | +221.11% | +800.78% | +498.54% | - | 41B | |
| -5.47% | +25.17% | +64.38% | +100.98% | +83.03% | +98.98% | +87.94% | +27.71% | +247.70% | 34.92B | |
| +1.22% | -1.44% | +4.36% | +2.62% | +11.15% | +14.57% | +47.05% | +13.40% | +156.98% | 32.82B | |
| -2.22% | +18.25% | -0.68% | +12.10% | -36.59% | -40.74% | +341.28% | +244.57% | +818.94% | 24.7B | |
| +0.27% | -2.83% | -18.24% | +14.95% | +41.86% | +25.21% | -5.11% | -60.18% | - | 23.27B | |
| -0.73% | +0.84% | -9.61% | -5.05% | -7.99% | -15.74% | -5.30% | -69.74% | - | 22.15B | |
| -1.17% | -4.46% | +7.86% | +12.79% | +15.13% | +8.85% | +144.33% | +185.06% | +2,067.62% | 18.24B | |
| -1.82% | -1.12% | +21.74% | +53.02% | +77.10% | +97.52% | +102.21% | -18.21% | +403.82% | 17.16B | |
| +0.73% | +2.77% | +18.03% | +30.44% | +41.60% | +46.83% | +77.57% | -15.69% | +120.40% | 17B | |
| +1.43% | +8.47% | +20.95% | +28.27% | +61.13% | +85.56% | +250.84% | +222.78% | +553.33% | 16.93B | |
| -0.79% | +2.18% | +9.92% | +2.89% | - | - | - | - | - | 16.5B | |
| -2.83% | +11.54% | +26.50% | +29.40% | +12.50% | +21.45% | -19.14% | -27.41% | +166.88% | 15.83B | |
| 0.00% | +2.59% | +1.71% | +12.26% | +180.86% | +165.07% | +345.26% | +1,394.79% | +769.37% | 15.11B | |
| +9.43% | +19.62% | +4.84% | +74.46% | +36.05% | -9.44% | - | - | - | 13.03B | |
| Average | -0.65% | +5.14% | +7.06% | +21.73% | +40.85% | +46.82% | +142.92% | +144.59% | +913.46% | 28.71B | |
| Weighted average by Cap. | -1.22% | +4.71% | +5.07% | +19.54% | +39.84% | +45.24% | +147.04% | +114.81% | +1,273.74% |
- Stock Market
- Stocks
- FOLD Stock
- Sector Amicus Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
